Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency

BACKGROUND: Primaquine is used to prevent Plasmodium vivax relapse; however, it is not implemented in many malaria-endemic countries, including Cambodia, for fear of precipitating primaquine-induced acute haemolytic anaemia in patients with glucose-6-phosphate dehydrogenase deficiency (G6PDd). Reluc...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Kheng, Sim, Muth, Sinoun, Taylor, Walter R. J., Tops, Narann, Kosal, Khem, Sothea, Khon, Souy, Phum, Kim, Saorin, Char, Chuor Meng, Vanna, Chan, Ly, Po, Ringwald, Pascal, Khieu, Virak, Kerleguer, Alexandra, Tor, Pety, Baird, John K., Bjorge, Steven, Menard, Didier, Christophel, Eva
Materialtyp: Online Artikel Text
Språk:English
Publicerad: BioMed Central 2015
Ämnen:
Research Article
Länkar:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549079/
https://www.ncbi.nlm.nih.gov/pubmed/26303162
http://dx.doi.org/10.1186/s12916-015-0441-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549079/
https://www.ncbi.nlm.nih.gov/pubmed/26303162
http://dx.doi.org/10.1186/s12916-015-0441-1

Liknande verk